USHAANTHY RAVINDRAN
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism SACRAMENTO, CA NPI 1992237622
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism CA Amgen Inc. All categories
General Payments — all program years on this page
$4,809.87
- Category: General Payments
- Program years: PY2018–2024
- Record count: 165
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,841.41 across 71 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,841.41 | 71 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $332.41 | 16 |
| BETA BIONICS, INC. | $227.91 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $179.72 | 4 |
| Radius Health, Inc. | $141.30 | 6 |
| Lilly USA, LLC | $134.80 | 7 |
| SANOFI-AVENTIS U.S. LLC | $119.65 | 6 |
| DEXCOM, INC. | $103.76 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $67.67 | 4 |
| Ascensia Diabetes Care US Inc. | $65.74 | 3 |
| Octapharma USA, Inc. | $58.02 | 2 |
| Corcept Therapeutics | $50.90 | 1 |
| Aurinia Pharma U.S., Inc. | $50.01 | 2 |
| Xeris Pharmaceuticals, Inc. | $49.77 | 3 |
| Novo Nordisk AS | $40.59 | 2 |
| ABBVIE INC. | $34.47 | 1 |
| Abbott Laboratories | $23.81 | 1 |
| Madrigal Pharmaceuticals | $23.57 | 1 |
| MannKind Corporation | $22.67 | 1 |
| Kyowa Kirin, Inc. | $21.53 | 1 |
| SCILEX PHARMACEUTICALS INC. | $21.42 | 1 |
| Genentech USA, Inc. | $19.29 | 1 |
| CHIESI USA, INC. | $19.24 | 1 |
| Averitas Pharma Inc. | $18.24 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $14.92 | 1 |
By program year
Records — PY2024 (71)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.